Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
about
Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidatesConstruction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactinCarbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cellsMutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.Maternal immunity provides protection against pertussis in newborn pigletsMicroparticles as vaccine adjuvants and delivery systems.Development of oral microencapsulated forms for delivering viral vaccines.Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.Antigen delivery systems.Pulmonary vaccine delivery.A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.Bioadhesive delivery systems for mucosal vaccine delivery.Recent advances in vaccine adjuvants for systemic and mucosal administration.Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.Intranasal immunization with Yersinia enterocolitica O:8 cellular extract protects against local challenge infection.Intranasal immunization against influenza virus using polymeric particles.Adjuvant activity of free Bordetella pertussis filamentous haemagglutinin delivered by mucosal routes.Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses.Uptake of ovalbumin-conjugated starch microparticles by pig respiratory nasal mucosa in vitro.
P2860
Q24657870-810DB4EF-339C-4B0E-911E-69FA97A128A0Q33295282-6EB861B8-E383-42C5-8712-B7C0E0752000Q33592225-0126A08C-4757-4E66-ACD7-850FB43602F5Q33601872-F4A37AD6-3085-45F7-A741-0798A75CDB30Q34002672-5BE6D1CC-84A5-430C-82F1-47101EDC66F5Q34601948-3228E1DE-75DE-436D-9575-FCFC40F3CCA4Q35192199-C755CB9F-9B08-4306-BA94-58307DDD520FQ35193482-1C1BD5F8-C7B2-4237-90CD-3EAD947F99ACQ35467763-4B6B9DAE-7E02-4B52-B4F3-298D6CB89293Q35843648-27357558-8A27-4216-9FAA-86850769D700Q36780141-9DA4EBE4-02C1-4335-9B53-3380ACF0E8B9Q37349215-ADDDE585-6B25-451A-B507-A18714EC4D9AQ37805519-BF3F33B0-5144-47F9-86D0-0489606E3A55Q38553059-38F0CB30-1404-42AE-BFBC-A82117E6D546Q39656008-94C45FCB-B7E6-42FC-9556-23F5CC423CDFQ39826183-D53C9086-6C71-4EF3-B421-BDC28E0B913DQ41484068-D566CB46-4888-483E-945E-7A630FD93B94Q43970626-6D578954-CA61-4625-AFED-DACE5BA1E4CDQ44663128-5382948B-CCDF-4584-B540-36C265860B04Q45385614-6C35B468-E8A3-4585-A676-1E81B8DBE73CQ45754936-B20199ED-A4DB-46CF-8E39-DAEFF21C6609Q51664235-457F7CBF-1643-4872-B4FE-B8AB8D240EF0
P2860
Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Immune responses and protectio ...... biodegradable microparticles.
@en
type
label
Immune responses and protectio ...... biodegradable microparticles.
@en
prefLabel
Immune responses and protectio ...... biodegradable microparticles.
@en
P2093
P921
P1433
P1476
Immune responses and protectio ...... biodegradable microparticles.
@en
P2093
P304
P356
10.1016/0264-410X(94)00008-B
P407
P577
1995-04-01T00:00:00Z